ArticleCureus2025
Retinal Complications in a Patient With Pediatric Thalassemia: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The authors report a case of retinal involvement in a pediatric patient with beta-thalassemia major, highlighting the importance of an early ophthalmologic assessment. A 10-year-old male with a known diagnosis of beta-thalassemia major presented with complaints of decreased visual acuity. A comprehensive ophthalmologic examination, including fundus evaluation and fluorescein angiography, was performed. The fundoscopic examination revealed a macular hemorrhage and marked vascular tortuosity. Imaging supported the presence of retinal hypoperfusion without signs of neovascularization. The retinal findings were attributed to chronic anemia and iron overload related to repeated blood transfusions. Retinal abnormalities can occur in patients with beta-thalassemia major due to systemic factors such as anemia and iron toxicity. Early detection through routine ophthalmologic screening is essential to prevent potentially irreversible visual impairment in this patient population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.